Allelix Neuroscience Inc.
12Patents
0Active
12Granted
31Portfolio score
Filing activity: May 31, 1996 → Feb 15, 2002
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6191165A | Pharmaceutical for treatment of neurological and neuropsychiatric disorders | Chemistry; Metallurgy | 20 | Expired |
| US6001854A | Pharmaceutical for treating of neurological and neuropsychiatric disorders | Chemistry; Metallurgy | 10 | Expired |
| US6166072A | Amino acid derivatives | Chemistry; Metallurgy | 8 | Expired |
| US5919653A | Nucleic acids encoding a human glycine transporter | Human Necessities | 7 | Expired |
| US6162824A | Tricylic amino-acid derivatives | Chemistry; Metallurgy | 5 | Expired |
| US6103743A | Unsaturated amino acid derivatives | Chemistry; Metallurgy | 4 | Expired |
| US7019024B2 | Pharmaceutical for treatment of neurological and neuropsychiatric disorders | Chemistry; Metallurgy | 4 | Expired |
| US5824486A | Glycine transporter-transfected cells and uses thereof | Chemistry; Metallurgy | 3 | Expired |
| US5968823A | Glycine transporter-transfected avian cells and uses thereof | Chemistry; Metallurgy | 2 | Expired |
| US6667336B2 | GlyT-1 inhibitors | Chemistry; Metallurgy | 1 | Expired |
| US6008015A | Glycine transporter | Emerging Cross-Sectional Technologies | 1 | Expired |
| US6251617A | Glycine transporter | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.